journal article
Open Access Collection
Science is the drug
2013 The EMBO Reports
doi: 10.1038/embor.2013.153pmid: 24287804
… in which Howy confesses to some eccentric proclivities.
doi: 10.1038/embor.2013.153pmid: 24287804
… in which Howy confesses to some eccentric proclivities.
doi: 10.1038/embor.2013.184pmid: 24287805
The ‘Drugs & Science’ series in EMBO reports will highlight the therapeutic, the risky and the societal aspects of drug use and abuse.
doi: 10.1038/embor.2013.174pmid: 24176931
Thirteen common misunderstandings about alternative medicine and the consequences for health.
Fackler, Oliver T; Keppler, Oliver T
doi: 10.1038/embor.2013.172pmid: 24176933
Three groups have recently shown in Nature and Cell Host & Microbe that MxB/Mx2 is an interferon‐inducible HIV restriction factor, adding to the innate arsenal of the cell against the virus and paving the way for the possible development of new antiviral strategies.
Dutta, Arnob; Workman, Jerry L
doi: 10.1038/embor.2013.166pmid: 24157947
Although chromatin remodellers are thought to exert power strokes to move nucleosomes along DNA, two studies in this issue show that a power stroke is not required for efficient remodelling, indicating that the DNA binding domain primarily tethers remodellers to nucleosomes.
Im, Jun‐Sub; Lee, Kyung Yong; Dillon, Laura W; Dutta, Anindya
doi: 10.1038/embor.2013.171pmid: 24189099
Huang and colleagues identify a human primase‐polymerase that is required for stalled replication fork restart and the maintenance of genome integrity.
Nielsen, David R; Moon, Tae Seok
doi: 10.1038/embor.2013.178pmid: 24201977
Synthetic biology has the potential to profoundly change the way we produce many chemicals, as well as to reduce the environmental impact of the chemical industry.
doi: 10.1038/embor.2013.177pmid: 24232184
Understanding disease causes and drug action at the molecular and systems levels could help to identify combinations of drugs that are more effective than individual drugs alone.
doi: 10.1038/embor.2013.180pmid: 24201975
Scientists are exploring crowdfunding as a potential new source of cash for their research.
Showing 1 to 10 of 23 Articles